Literature DB >> 28176629

Congenital Hypothyroidism: Facts, Facets & Therapy.

Yedukondalu Kollati1, Ranga Rao Ambati2, Prakash Narayana Reddy1, N Satya Sampath Kumar1, Rajesh K Patel3, Vijaya R Dirisala4.   

Abstract

BACKGROUND: Thyroid hormone (T3) is essential for normal development of children enabling brain development and somatic growth. However, certain individuals are genetically predisposed with insufficient or no thyroid hormones. Such a condition is termed congenital hypothyroidism (CH).
OBJECTIVE: In the present review, a brief back ground about congenital hypothyroidism, factors associated with CH leading to thyroid dysgenesis and thyroid dyshormonogenesis is elaborated. Additionally, the guidelines for available treatment options, management and follow-up required for patients diagnosed with CH are discussed. Treatment options in terms of treatment initiation and dosage of hormone replacement are discussed.
CONCLUSION: Though CH is considered as the most common neonatal metabolic disorder, it is also easily treatable compared to other metabolic or hereditary diseases. The outcome of CH treatment depends on the compliance of parents early in life and by patients themselves during later part of life. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Congenital hypothyroidism; Thyroid hormone (T3); hormone therapy; levothyroxine; thyroid gland; transcription factors

Mesh:

Substances:

Year:  2017        PMID: 28176629     DOI: 10.2174/1381612823666170206124255

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  The rs1991517 polymorphism is a genetic risk factor for congenital hypothyroidism.

Authors:  Yedukondalu Kollati; Radha Rama Devi Akella; Shaik Mohammad Naushad; Maunika Thalla; G Bhanuprakash Reddy; Vijaya R Dirisala
Journal:  3 Biotech       Date:  2020-06-01       Impact factor: 2.406

Review 2.  Evaluation and management of the child with hypothyroidism.

Authors:  Alexander K C Leung; Alexander A C Leung
Journal:  World J Pediatr       Date:  2019-02-08       Impact factor: 2.764

3.  microRNA-124-3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6.

Authors:  Wenjie Li; Dongpo Song; Yingmei Sun; Yanan Lv; Jinfeng Lv
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

4.  An Alport syndrome boy with Van Wyk-Grumbach syndrome induced by prolonged untreated congenital hypothyroidism.

Authors:  Su-Jeong Lee; Jung-Eun Moon; Gi-Min Lee; Min-Hyun Cho; Cheol Woo Ko
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-06-30

5.  Effect of Levothyroxine Treatment on Incident Dementia in Adults with Atrial Fibrillation and Hypothyroidism.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Kristina Sundquist
Journal:  Clin Drug Investig       Date:  2019-02       Impact factor: 2.859

6.  Levothyroxine treatment and incident dementia in adults with atrial fibrillation.

Authors:  Per Wändell; Axel C Carlsson; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Aging Clin Exp Res       Date:  2019-05-22       Impact factor: 3.636

7.  Role of sirtuin 1 in the brain development in congenital hypothyroidism rats via the regulation of p53 signaling pathway.

Authors:  Xiaofang Wei; Juan Tan; Hui Gao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.